Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
Chang Chen, Jianying Huang, Ping Yin, Yi Zhang, Zhenshun Cheng, Jianyuan Wu, Song Chen, Yongxi Zhang, Bo Chen, Mengxin Lu, Yongwen Luo, Jingyi Zhang, View ORCID ProfileXinghuan Wang
doi: https://doi.org/10.1101/2020.03.17.20037432
Chang Chen
1Clinical Trial Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
2Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
MDJianying Huang
1Clinical Trial Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
3Wuhan Leishenshan Hospital, Wuhan, Hubei, 430000, China
MDPing Yin
4Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China
PhDYi Zhang
5Center for Life Sciences, Peking University, Beijing, 100871, China
6Euler Technology, ZGC Life Sciences Park, Beijing, 102200, China
PhDZhenshun Cheng
7Department of Respiratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
MDJianyuan Wu
1Clinical Trial Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
3Wuhan Leishenshan Hospital, Wuhan, Hubei, 430000, China
PhDSong Chen
8Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
MDYongxi Zhang
9Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
MDBo Chen
1Clinical Trial Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
3Wuhan Leishenshan Hospital, Wuhan, Hubei, 430000, China
PhDMengxin Lu
8Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
MDYongwen Luo
8Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
MDJingyi Zhang
10Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei, 430033, China
MDXinghuan Wang
1Clinical Trial Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
3Wuhan Leishenshan Hospital, Wuhan, Hubei, 430000, China
5Center for Life Sciences, Peking University, Beijing, 100871, China
11Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China
MD, PhD
Article usage
Posted April 08, 2020.
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
Chang Chen, Jianying Huang, Ping Yin, Yi Zhang, Zhenshun Cheng, Jianyuan Wu, Song Chen, Yongxi Zhang, Bo Chen, Mengxin Lu, Yongwen Luo, Jingyi Zhang, Xinghuan Wang
medRxiv 2020.03.17.20037432; doi: https://doi.org/10.1101/2020.03.17.20037432
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
Chang Chen, Jianying Huang, Ping Yin, Yi Zhang, Zhenshun Cheng, Jianyuan Wu, Song Chen, Yongxi Zhang, Bo Chen, Mengxin Lu, Yongwen Luo, Jingyi Zhang, Xinghuan Wang
medRxiv 2020.03.17.20037432; doi: https://doi.org/10.1101/2020.03.17.20037432
Subject Area
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (218)
- Cardiovascular Medicine (3219)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13236)
- Forensic Medicine (19)
- Gastroenterology (889)
- Genetic and Genomic Medicine (5056)
- Geriatric Medicine (469)
- Health Economics (772)
- Health Informatics (3178)
- Health Policy (1127)
- Hematology (423)
- HIV/AIDS (999)
- Medical Education (468)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4802)
- Nursing (254)
- Nutrition (715)
- Oncology (2474)
- Ophthalmology (701)
- Orthopedics (278)
- Otolaryngology (337)
- Pain Medicine (320)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1276)
- Primary Care Research (550)
- Public and Global Health (7364)
- Radiology and Imaging (1668)
- Respiratory Medicine (967)
- Rheumatology (473)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (69)
- Transplantation (231)
- Urology (199)